No Ads for High-Risk Medicines: Govt Panel Recommends Major Amendments to Drugs Rules 1945 Written By Susmita Roy8 Dec 2025 12:15 PM ISTNew Delhi: In a significant move aimed at tightening regulatory control over the promotion of high-risk medicines, the Drugs Consultative Committee...
MSD Pharma Gets Conditional SEC Approval to Begin Phase III Trial of Sacituzumab Tirumotecan Written By Susmita Roy7 Dec 2025 11:08 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting permission to MSD...
WHO Alert Spurs India's Probe Into Deadly Cough Syrup, Licence Cancelled, 700 Plus Units Audited, Parliament Informed Written By Susmita Roy6 Dec 2025 11:22 PM ISTNew Delhi: In response to the World Health Organization's alert of 13 October 2025 on contaminated cough syrups linked to child deaths, the Union...
CDSCO Panel Seeks Protocol Revisions in Levim Lifetech's Teriparatide Biosimilar Study Written By Susmita Roy6 Dec 2025 11:02 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has opined that LevimLifetech revise the...
Same Brand Name Used for Multiple Drugs: Govt Panel Calls for Stakeholder Consultation Written By Susmita Roy6 Dec 2025 10:51 PM ISTNew Delhi: In a move aimed at addressing growing concerns over brand name extensions in the pharmaceutical sector, the Drugs Consultative Committee...
Govt Panel Approves Inclusion of Emergency Contraceptive Levonorgestrel Under Schedule K Written By Susmita Roy4 Dec 2025 9:52 PM ISTNew Delhi: In a move aimed at streamlining regulatory clarity and improving access to essential reproductive health products, the Drugs Consultative...
CDSCO Panel Denies Trial Waiver for Atropine, Asks Sun Pharma to Conduct Phase III Study Written By Susmita Roy4 Dec 2025 8:57 PM ISTNew Delhi: Rejecting the proposal for a clinical trial waiver for Atropine Sulphate Ophthalmic Solution IP 0.025% w/v, the Subject Expert Committee...
CDSCO Issues Risk Classification List for 187 Interventional Radiology Devices, Details Written By Susmita Roy3 Dec 2025 5:31 PM ISTNew Delhi: In a move to streamline regulatory oversight of medical devices, the Central Drugs Standard Control Organisation (CDSCO) has released the...
Lupin's Phase IV Report for Glycopyrronium, Vilanterol Inhalation Gets CDSCO Panel Nod Written By Parthika Patel3 Dec 2025 5:02 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has accepted the Phase IV clinical trial...
Alkem Gets CDSCO Panel Nod to Market Synthetic Semaglutide Injection in Multiple Strengths for Type 2 Diabetes Written By Susmita Roy2 Dec 2025 10:22 PM ISTNew Delhi: Alkem Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control...
CDSCO Panel Approves Akums' Proposal to Manufacture, Market Nitisinone Dispersible Tablets for Hereditary Tyrosinemia Type 1 Written By Susmita Roy30 Nov 2025 4:00 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has recommended granting...
Sanofi Gets CDSCO Panel Nod to Update Prescribing Information for Xenpozyme Written By Susmita Roy29 Nov 2025 10:37 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has recommended approval for...
